BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gul M, Jafari AA, Shah M, Mirmoeeni S, Haider SU, Moinuddin S, Chaudhry A. Molecular Biomarkers in Multiple Sclerosis and Its Related Disorders: A Critical Review. Int J Mol Sci 2020;21:E6020. [PMID: 32825639 DOI: 10.3390/ijms21176020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Ju C, Yuan F, Wang L, Zang C, Ning J, Shang M, Ma J, Li G, Yang Y, Chen Q, Jiang Y, Li F, Bao X, Zhang D. Inhibition of CXCR2 enhances CNS remyelination via modulating PDE10A/cAMP signaling pathway. Neurobiol Dis 2023;177:105988. [PMID: 36603746 DOI: 10.1016/j.nbd.2023.105988] [Reference Citation Analysis]
2 Zhu W, Chen C, Zhang L, Hoyt T, Walker E, Venkatesh S, Zhang F, Qureshi F, Foley JF, Xia Z. Association between Serum Biomarker Profile and Real-World Evidence of Disability in Multiple Sclerosis.. [DOI: 10.1101/2022.10.21.22281364] [Reference Citation Analysis]
3 Qureshi F, Hu W, Loh L, Patel H, Deguzman M, Becich M, Rubio da Costa F, Gehman V, Zhang F, Foley J, Chitnis T. Analytical validation of a multivariate proteomic serum-based assay for disease activity assessments in multiple sclerosis.. [DOI: 10.1101/2022.05.23.22275201] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Mathur D, Mishra BK, Rout S, Lopez-Iranzo FJ, Lopez-Rodas G, Vallamkondu J, Kandimalla R, Casanova B. Potential Biomarkers Associated with Multiple Sclerosis Pathology. Int J Mol Sci 2021;22:10323. [PMID: 34638664 DOI: 10.3390/ijms221910323] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
5 Han MM, Yuan XR, Shi X, Zhu XY, Su Y, Xiong DK, Zhang XM, Zhou H, Wang JN. The Pathological Mechanism and Potential Application of IL-38 in Autoimmune Diseases. Front Pharmacol 2021;12:732790. [PMID: 34539413 DOI: 10.3389/fphar.2021.732790] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
6 Zhang Q, Dai X, Zhang H, Zeng Y, Luo K, Li W. Recent advances in development of nanomedicines for multiple sclerosis diagnosis. Biomed Mater 2021;16:024101. [PMID: 33472182 DOI: 10.1088/1748-605X/abddf4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]